pteridines has been researched along with Glioma in 6 studies
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
Excerpt | Relevance | Reference |
---|---|---|
" Here we analyze in vitro the antiproliferative efficacy, apoptotic properties and effects of three new disilver complexes containing E-6-(hydroxyimino)ethyl-1,3,7-trimethyllumazine (lumazine=pteridine-2,4(1H,3H)-dione) on RAS-regulating APA and APN specific activities in human neuroblastoma and glioma cell lines NB69 and U373-MG." | 7.80 | Silver(I)/6-hydroxyiminolumazine compounds differently modify renin-angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells. ( Carrera-González, MP; Hueso-Ureña, F; Illán-Cabeza, NA; Jiménez-Pulido, SB; Martínez-Martos, JM; Mayas-Torres, MD; Moreno-Carretero, MN; Ramírez-Expósito, MJ; Sánchez-Sánchez, P, 2014) |
" Here we analyze in vitro the antiproliferative efficacy, apoptotic properties and effects of three new disilver complexes containing E-6-(hydroxyimino)ethyl-1,3,7-trimethyllumazine (lumazine=pteridine-2,4(1H,3H)-dione) on RAS-regulating APA and APN specific activities in human neuroblastoma and glioma cell lines NB69 and U373-MG." | 3.80 | Silver(I)/6-hydroxyiminolumazine compounds differently modify renin-angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells. ( Carrera-González, MP; Hueso-Ureña, F; Illán-Cabeza, NA; Jiménez-Pulido, SB; Martínez-Martos, JM; Mayas-Torres, MD; Moreno-Carretero, MN; Ramírez-Expósito, MJ; Sánchez-Sánchez, P, 2014) |
"Gliomas are the most devastating of primary adult malignant brain tumors." | 1.38 | Glioma-propagating cells as an in vitro screening platform: PLK1 as a case study. ( Ang, BT; Brooks, HB; Campbell, RM; Chong, YK; Foong, CS; Sandanaraj, E; Tang, C, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Li, X | 1 |
Tao, Z | 1 |
Wang, H | 2 |
Deng, Z | 1 |
Zhou, Y | 1 |
Du, Z | 1 |
Zhu, Z | 1 |
Wang, J | 1 |
Tan, J | 1 |
Yao, YL | 1 |
He, ZC | 1 |
Xie, XQ | 1 |
Yan, ZX | 1 |
Fu, WJ | 1 |
Liu, Q | 1 |
Wang, YX | 1 |
Luo, T | 1 |
Bian, XW | 1 |
Ramírez-Expósito, MJ | 1 |
Mayas-Torres, MD | 1 |
Carrera-González, MP | 1 |
Jiménez-Pulido, SB | 1 |
Illán-Cabeza, NA | 1 |
Sánchez-Sánchez, P | 1 |
Hueso-Ureña, F | 1 |
Martínez-Martos, JM | 1 |
Moreno-Carretero, MN | 1 |
Amani, V | 1 |
Prince, EW | 1 |
Alimova, I | 1 |
Balakrishnan, I | 1 |
Birks, D | 1 |
Donson, AM | 1 |
Harris, P | 1 |
Levy, JM | 1 |
Handler, M | 1 |
Foreman, NK | 1 |
Venkataraman, S | 1 |
Vibhakar, R | 1 |
Liu, KK | 1 |
Bagrodia, S | 1 |
Bailey, S | 1 |
Cheng, H | 1 |
Chen, H | 1 |
Gao, L | 1 |
Greasley, S | 1 |
Hoffman, JE | 1 |
Hu, Q | 1 |
Johnson, TO | 1 |
Knighton, D | 1 |
Liu, Z | 1 |
Marx, MA | 1 |
Nambu, MD | 1 |
Ninkovic, S | 1 |
Pascual, B | 1 |
Rafidi, K | 1 |
Rodgers, CM | 1 |
Smith, GL | 1 |
Sun, S | 1 |
Yang, A | 1 |
Yuan, J | 1 |
Zou, A | 1 |
Foong, CS | 1 |
Sandanaraj, E | 1 |
Brooks, HB | 1 |
Campbell, RM | 1 |
Ang, BT | 1 |
Chong, YK | 1 |
Tang, C | 1 |
6 other studies available for pteridines and Glioma
Article | Year |
---|---|
Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzodioxoles; Brain Neoplasms; Cell Cycle Proteins; Cell | 2020 |
Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target.
Topics: Adult; Aged; Animals; Apoptosis; Brain Neoplasms; Calcium-Binding Proteins; Cell Cycle; Cell Prolife | 2021 |
Silver(I)/6-hydroxyiminolumazine compounds differently modify renin-angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells.
Topics: Antineoplastic Agents; Apoptosis; CD13 Antigens; Cell Line, Tumor; Glioma; Glutamyl Aminopeptidase; | 2014 |
Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma.
Topics: Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damag | 2016 |
4-methylpteridinones as orally active and selective PI3K/mTOR dual inhibitors.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Glioma; Humans; Mice; Models | 2010 |
Glioma-propagating cells as an in vitro screening platform: PLK1 as a case study.
Topics: Animals; Brain Neoplasms; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Computational Biol | 2012 |